Using Acupuncture and Moxibustion to Promote Wellbeing and Improve Quality of Life for Patients With Upper Body Lymphoedema Secondary to Cancer Treatment
- To test the acupuncture and moxibustion treatment strategies to obtain a first measure
of response for the approach(es) used in patients with breast cancer or head, neck, and
throat cancer undergoing standard treatment for secondary lymphedema.
- To assess whether this treatment is an acceptable intervention to cancer patients with
secondary lymphedema and to their health care professionals.
- To disseminate the data to begin to build the evidence base for using this treatment in
the management of lymphedema.
OUTLINE: Patients undergo acupuncture and moxibustion therapy once weekly for 7 treatment
(Series 1). After completion of therapy, patients may choose to continue treatment for an
additional 6 treatments (Series 2).
Patients complete a set of 4 questionnaires (i.e., sociodemographic, Short-Form-36, Positive
and Negative Affect Scale (PANAS), and Measure Yourself Medical Outcome Profile (MYMOP)) at
the first treatment and then periodically during study. Patients also complete a series of
follow-up questionnaires designed to elicit feedback about their acupuncture experience.
After completion of study treatment, patients are followed at 1 and 3 months.
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Change From Baseline in Patient-specified and Reported Symptoms on the Measure Yourself Medical Outcome Profile (MYMOP)
MYMOP is a questionnaire widely used for evaluating interventions based on holistic and participative principles. It enables respondants to specify and measure the treatment outcomes that are important to them.
Before 7th acupuncture treatment
Beverley de Valois, PhD LicAc
Lynda Jackson Macmillan Centre at Mount Vernon Hospital
United Kingdom: National Health Service